Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 213-192-8 | CAS number: 928-96-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 14 March 2012 to 27 March 2012
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 012
- Report date:
- 2012
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- No analysis was carried out to determine the homogeneity, concentration or stability of the test item formulation. This exception is considered not to affect the purpose or integrity of the study.
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- cis-hex-3-en-1-ol
- EC Number:
- 213-192-8
- EC Name:
- cis-hex-3-en-1-ol
- Cas Number:
- 928-96-1
- Molecular formula:
- C6H12O
- IUPAC Name:
- hex-3-en-1-ol
- Test material form:
- liquid
- Details on test material:
- - Name of test material (as cited in study report): Cis-hex-3-en-ol, LFA
- Physical state: clear, colourless liquid
- Analytical purity: 98.59 %
- Lot/batch No.: 1Z50650
- Expiration date of the lot/batch: 06 June 2015
- Storage condition of test material: room temperature in the dark under nitrogen
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- other: CBA/Ca (CBA/CaOlaHsd
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Harlan Laboratories UK Ltd, Oxon, UK
- Age at study initiation: 8 to 12 weeks old
- Weight at study initiation: 15 to 23 g
- Housing: the animals were individually housed in suspended solid-floor polypropylene cages furnished with softwood woodflakes. The animals were provided with environmental enrichment which were considered not to contain any contaminant of a level that might have affected the purpose or integrity of the study.
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: at least 5 d
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19 to 25
- Humidity (%): 30 to 70
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12/12
Study design: in vivo (LLNA)
- Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- 100, 50 and 25 %
- No. of animals per dose:
- 4/dose
- Details on study design:
- RANGE FINDING TESTS:
Using available information regarding the systemic toxicity/ irritancy potential of the test item, a preliminary screening test was performed using one mouse. The mouse was treated by daily application of 25 µL of the undiluted test item to the dorsal surface of each ear for 3 consecutive days (Day 1, 2 3). The mouse was observed twice daily on Days 1, 2 and 3 and once on Days 4,5 and 6. Local irritation was scored daily. Any clinical of toxicity, if present, were also recorded. The bodyweight was recorded on Day 1 (prior to dosing) and on day 6.
The thickness of each ear was measured using an Oditest micrometer (Dyer, PA), pre-dose on Day 1, post dose on Day 3 and on Day 6, any changes in the ear thickness were noted. Mean ear thickness changes increase of equal to or greater than 25 % was considered to indicate excessive irritation and limited biological relevance to the endpoint of sensitisation.
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
The mice were treated by daily application of 25 µL of the appropriate concentration of the test item to the dorsal surface of each ear for 3 consecutive days (Day 1, 2 and 3). The test item formulation was administered using an automatic micropipette and spread over the dorsal surface of the ear using the tip of the pipette.
A further 4 mice received vehicle alone in the same manner
Five days following the first topical application of the test item or vehicle (Day 6) all mice were injected via the tail vein with 250 µL of phosphate buffered saline (PBS) containing 3H-methyl thymidine (3HTdR: 80 µCi/mL, specific activity 20. Ci/ mmol, ARC UK Ltd) giving a total of 20 µCi to each mouse. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
Results and discussion
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Value:
- 1.31
- Test group / Remarks:
- 25%
- Remarks on result:
- other: non-sensitising
- Parameter:
- SI
- Value:
- 1.52
- Test group / Remarks:
- 50%
- Remarks on result:
- other: non-sensitising
- Parameter:
- SI
- Value:
- 1.74
- Test group / Remarks:
- 100%
- Remarks on result:
- other: non-sensitising
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: Vehicle: 8625.33; 25 %: 11305.86; 50 %: 13138.66 ;100 %: 15037.68
Any other information on results incl. tables
Preliminary screening test
No signs of systemic toxicity, visual skin irritation or irritation indicated by an equal to or greater than 25 % increase in mean ear thickness were noted.
Based on this information the undiluted test item and the test item at concentrations of 50 % and 25 % v/v in acetone/ olive oil 4:1 were selected for the main test.
Main test
Estimation of the proliferative response of lymph node cells
Disintegrations per minute, disintegrations per minute/ node and Stimulation index
Concentration (% v/v) in acetone/ olive oil 4:1 |
dpm |
dpm/Nodea |
Stimulation Indexb |
Result |
Vehicle |
8625.33 |
1078.17 |
na |
na |
25 |
11305.86 |
1413.23 |
1.31 |
Negative |
50 |
13138.66 |
1642.33 |
1.52 |
Negative |
100 |
15037.68 |
1879.71 |
1.74 |
Negative |
dpm= Disintegrations per minute
a= Disintegrations per minute/ node obtained by dividing the disintegrations per minute value by 8 (total number of lymph nodes)
b= Stimulation Index of 3.0 or greater indicates a positive result
na= Not applicable
The Stimulation Index is expressed as the mean radioactive incorporation for each treatment group divided by the mean radioactive incorporation of the vehicle control group.
Clinical observations and mortality data
There were no deaths. No signs of systemic toxicity were noted in the test or control animals during the test.
Bodyweight
Bodyweight changes of the test animals between Day 1 and Day 6 were comparable to those observed in the corresponding control group of animals over the same period.
Current positive control study for the local lymph node assay
The Stimulation Index expressed as the mean radioactive incorporation for the treatment group divided by the mean radioactive incorporation of the vehicle control group is as follows:
Concentration (% v/v) in acetone/ olive oil 4:1 |
Stimulation Index |
Result |
25 |
5.76 |
Positive |
α-Hexylcinnamaldehyde, tech., 85% was considered to be a sensitizer under the conditions of the test.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The sensitising potential of the test item was assessed according to OECD guideline 429. The test item was considered to be a non-sensitiser.
- Executive summary:
Introduction.
A study was performed to assess the skin sensitisation potential of the test item in the CBA/Ca strain mouse following topical application to the dorsal surface of the ear. The method was designed to be compatible with the OECD Guideline No. 429 "Skin Sensitisation: Local Lymph Node Assay".
Methods:
Following a preliminary screening test in which no clinical signs of toxicity were noted at a concentration of 100% this concentration was selected as the highest dose investigated in the main test of the Local Lymph Node Assay.
Three groups of four CBA/Ca strain mice were treated with 50 µL (25 µL per ear) of the undiluted test item or the test item as a solution in acetone/ olive oil 4:1 at concentrations of 50 % or 25 % v/v. A further group of four animals was treated with acetone/olive oil 4:1 alone.
Results:
The Stimulation Index expressed as the mean radioactive incorporation for each treatment group divided by the mean radioactive incorporation of the vehicle control group are as follows:
Concentration (% v/v) in acetone/olive oil 4:1
Stimulation Index
Result
25
1.31
Negative
50
1.52
Negative
100
1.74
Negative
Conclusion:
The test item was considered to be a non-sensitiser under the conditions of the test.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.